{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:08Z","timestamp":1759336208039},"reference-count":61,"publisher":"AACN Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"abstract":"<jats:p>Heart failure is a burdensome cardiovascular condition associated with high rates of morbidity and mortality. The 3-month period after hospitalization is a vulnerable phase in which patients are at high risk for mortality and rehospitalization. To reduce risk during this period, patients with heart failure and reduced ejection fraction should receive guideline-directed pharmacological therapies\u2014the right drugs at the right doses\u2014before hospital discharge. Optimal pharmacotherapies for these patients include agents that suppress the renin-angiotensin-aldosterone system, suppress the sympathetic nervous system, enhance vasodilation, slow heart rate when needed, and reduce excess volume. Because optimal prescription and adherence are both necessary to ensure the best clinical outcomes, nurses need to participate in interventions that optimize prescription and drug use over time. Collaboration with pharmacists and advanced practice acute care nurses may help ensure that medication selection and dosing are consistent with national guidelines. Use of a predischarge order set and electronic medical records checklist can enhance collaborative care.<\/jats:p>","DOI":"10.4037\/ccn2018669","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:05:42Z","timestamp":1538381142000},"page":"16-24","source":"Crossref","is-referenced-by-count":2,"title":["In-Hospital Initiation of Guideline-Directed Heart Failure Pharmacotherapy to Improve Long-Term Patient Adherence and Outcomes"],"prefix":"10.4037","volume":"38","author":[{"given":"Nancy M.","family":"Albert","sequence":"first","affiliation":[{"name":"Nancy M. Albert is associate chief nursing officer, Office of Nursing Research and Innovation, and a clinical nurse specialist, Kaufman Center for Heart Failure, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.","family":"Kozinn","sequence":"additional","affiliation":[{"name":"Marc J. Kozinn is US cardiovascular medical director, heart failure, Amgen, Inc, Thousand Oaks, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","reference":[{"issue":"10","key":"2019112612174391100_b1-0380016","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"2019112612174391100_b2-0380016","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"14","key":"2019112612174391100_b3-0380016","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2019112612174391100_b4-0380016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2012.216476","article-title":"Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia","volume":"309","author":"Dharmarajan","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"2019112612174391100_b5-0380016","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","article-title":"The vulnerable phase after hospitalization for heart failure","volume":"12","author":"Greene","year":"2015","journal-title":"Nature Rev Cardiol"},{"issue":"5","key":"2019112612174391100_b6-0380016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ahj.2010.02.023","article-title":"Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program","volume":"159","author":"O\u2019Connor","year":"2010","journal-title":"Am Heart J"},{"issue":"1","key":"2019112612174391100_b7-0380016","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12872-016-0371-7","article-title":"What is the impact of systems of care for heart failure on patients diagnosed with heart failure: a systematic review","volume":"16","author":"Driscoll","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"17","key":"2019112612174391100_b8-0380016","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"2019112612174391100_b9-0380016","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamacardio.2016.0001","article-title":"Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction","volume":"1","author":"Faridi","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2019112612174391100_b10-0380016","doi-asserted-by":"crossref","first-page":"e009364","DOI":"10.1136\/bmjopen-2015-009364","article-title":"Effectiveness of implementation strategies in improving physician adherence to guideline recommendations in heart failure: a systematic review protocol","volume":"6","author":"Van Spall","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"2019112612174391100_b11-0380016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hfc.2016.07.001","article-title":"Understanding heart failure","volume":"13","author":"Mazurek","year":"2017","journal-title":"Heart Fail Clin"},{"issue":"21","key":"2019112612174391100_b12-0380016","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2019112612174391100_b13-0380016","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"2019112612174391100_b14-0380016","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"9744","key":"2019112612174391100_b15-0380016","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"2019112612174391100_b16-0380016","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2012.03.067","article-title":"Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study","volume":"60","author":"Bradley","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2019112612174391100_b17-0380016","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-155-8-201110180-00008","article-title":"Interventions to reduce 30-day rehospitalization: a systematic review","volume":"155","author":"Hansen","year":"2011","journal-title":"Ann Intern Med"},{"issue":"11","key":"2019112612174391100_b18-0380016","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"2019112612174391100_b19-0380016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/phar.1701","article-title":"Pharmacotherapy treatment patterns, outcomes, and health resource utilization among patients with heart failure with reduced ejection fraction at a U.S. academic medical center","volume":"36","author":"Bress","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2019112612174391100_b20-0380016","first-page":"pii:e004675","article-title":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction","volume":"6","author":"Gilstrap","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"2019112612174391100_b21-0380016","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.294.10.1240","article-title":"Risk-treatment mismatch in the pharmacotherapy of heart failure","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"2019112612174391100_b22-0380016","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ahj.2011.01.027","article-title":"Potential impact of optimal implementation of evidence-based heart failure therapies on mortality","volume":"161","author":"Fonarow","year":"2011","journal-title":"Am Heart J"},{"issue":"3 suppl 3","key":"2019112612174391100_b23-0380016","first-page":"S2","article-title":"The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes","author":"Fonarow","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"2019112612174391100_b24-0380016","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ahj.2015.10.026","article-title":"Discharge heart rate and beta-blocker dose in patients hospitalized with heart failure: findings from the OPTIMIZE-HF registry","volume":"173","author":"DeVore","year":"2016","journal-title":"Am Heart J"},{"issue":"1","key":"2019112612174391100_b25-0380016","doi-asserted-by":"crossref","first-page":"93.e9","DOI":"10.1016\/j.amjmed.2016.07.030","article-title":"All-payer analysis of heart failure hospitalization 30-day readmission: comorbidities matter","volume":"130","author":"Davis","year":"2017","journal-title":"Am J Med"},{"issue":"1","key":"2019112612174391100_b26-0380016","first-page":"62","article-title":"Prehospital delay, precipitants of admission, and length of stay in patients with exacerbation of heart failure","volume":"26","author":"Lee","year":"2016","journal-title":"Am J Crit Care"},{"issue":"7","key":"2019112612174391100_b27-0380016","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.jval.2015.09.788","article-title":"Association between adherence to evidence-based heart failure drug treatment and one-year all-cause hospitalization and all-cause mortality","volume":"18","author":"Moisan","year":"2015","journal-title":"Value Health"},{"issue":"2","key":"2019112612174391100_b28-0380016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2008.10.001","article-title":"Defining an evidence-based cutpoint for medication adherence in heart failure","volume":"157","author":"Moser","year":"2009","journal-title":"Am Heart J"},{"issue":"8","key":"2019112612174391100_b29-0380016","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cardfail.2011.04.011","article-title":"Impact of medication nonadherence on hospitalizations and mortality in heart failure","volume":"17","author":"Fitzgerald","year":"2011","journal-title":"J Card Fail"},{"issue":"9502","key":"2019112612174391100_b30-0380016","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"2019112612174391100_b31-0380016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10865-017-9829-z","article-title":"Depressive symptoms moderate the relationship between medication regimen complexity and objectively measured medication adherence in adults with heart failure","volume":"40","author":"Goldstein","year":"2017","journal-title":"J Behav Med"},{"key":"2019112612174391100_b32-0380016","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-022613-090415","article-title":"Reducing hospital readmission rates: current strategies and future directions","volume":"65","author":"Kripalani","year":"2014","journal-title":"Ann Rev Med"},{"issue":"4","key":"2019112612174391100_b33-0380016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/nur.21663","article-title":"Predictors of medication nonadherence differ among black and white patients with heart failure","volume":"38","author":"Dickson","year":"2015","journal-title":"Res Nurs Health"},{"issue":"3","key":"2019112612174391100_b34-0380016","first-page":"e197","article-title":"Factors affecting medication adherence trajectories for patients with heart failure","volume":"21","author":"Juarez","year":"2015","journal-title":"Am J Manag Care"},{"issue":"6","key":"2019112612174391100_b35-0380016","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ejhf.493","article-title":"Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT","volume":"18","author":"Bohm","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2019112612174391100_b36-0380016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","article-title":"A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity","volume":"9","author":"Gellad","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"issue":"12","key":"2019112612174391100_b37-0380016","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1525-1497.2006.00591.x","article-title":"Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy","volume":"21","author":"Gazmararian","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2019112612174391100_b38-0380016","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2013.1113","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"Clin Med Res"},{"issue":"1","key":"2019112612174391100_b39-0380016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jemermed.2013.04.060","article-title":"Heart failure beliefs and self-care adherence while being treated in an emergency department","volume":"46","author":"Albert","year":"2014","journal-title":"J Emerg Med"},{"issue":"6","key":"2019112612174391100_b40-0380016","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.hrtlng.2016.08.003","article-title":"A qualitative secondary data analysis of intentional and unintentional medication nonadherence in adults with chronic heart failure","volume":"45","author":"Riegel","year":"2016","journal-title":"Heart Lung"},{"issue":"1","key":"2019112612174391100_b41-0380016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.hrtlng.2007.02.003","article-title":"Factors influencing medication adherence in patients with heart failure","volume":"37","author":"Wu","year":"2008","journal-title":"Heart Lung"},{"issue":"12","key":"2019112612174391100_b42-0380016","doi-asserted-by":"crossref","first-page":"pii:e002475","DOI":"10.1161\/CIRCHEARTFAILURE.116.002475","article-title":"Association between poorer cognitive function and reduced objectively monitored medication adherence in patients with heart failure","volume":"9","author":"Dolansky","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"4","key":"2019112612174391100_b43-0380016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1067\/mhl.2001.116011","article-title":"Relationship between psychosocial variables and compliance in patients with heart failure","volume":"30","author":"Evangelista","year":"2001","journal-title":"Heart Lung"},{"issue":"2","key":"2019112612174391100_b44-0380016","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","article-title":"Trends in comorbidity, disability, and polypharmacy in heart failure","volume":"124","author":"Wong","year":"2011","journal-title":"Am J Med"},{"issue":"4","key":"2019112612174391100_b45-0380016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.healthpol.2017.02.008","article-title":"Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure","volume":"121","author":"Gourzoulidis","year":"2017","journal-title":"Health Policy"},{"issue":"3","key":"2019112612174391100_b46-0380016","doi-asserted-by":"crossref","first-page":"e002493","DOI":"10.1161\/JAHA.115.002493","article-title":"Barriers to adoption of miner-alocorticoid receptor antagonists in patients with heart failure: a mixed-methods study","volume":"5","author":"Dev","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2019112612174391100_b47-0380016","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.2005.02387.x","article-title":"Pharmaceutical care of patients with heart failure","volume":"60","author":"Sadik","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2019112612174391100_b48-0380016","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ahj.2015.01.006","article-title":"Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: a randomized intervention in high-risk patients","volume":"169","author":"Granger","year":"2015","journal-title":"Am Heart J"},{"issue":"5","key":"2019112612174391100_b49-0380016","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ahj.2005.08.016","article-title":"Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure","volume":"150","author":"Gwadry-Sridhar","year":"2005","journal-title":"Am Heart J"},{"issue":"19","key":"2019112612174391100_b50-0380016","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2015.09.025","article-title":"The role of the clinical pharmacist in the care of patients with cardiovascular disease","volume":"66","author":"Dunn","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2019112612174391100_b51-0380016","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archinte.168.7.687","article-title":"Pharmacist care of patients with heart failure: a systematic review of randomized trials","volume":"168","author":"Koshman","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"2019112612174391100_b52-0380016","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11897-017-0323-2","article-title":"Role of the pharmacist for improving self-care and outcomes in heart failure","volume":"14","author":"Parajuli","year":"2017","journal-title":"Curr Heart Fail Rep"},{"issue":"22","key":"2019112612174391100_b53-0380016","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/01.CIR.0000070952.08969.5B","article-title":"Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure","volume":"107","author":"Ansari","year":"2003","journal-title":"Circulation"},{"key":"2019112612174391100_b54-0380016","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2019112612174391100_b55-0380016","article-title":"Care of the chronically ill patients","volume-title":"Core Curriculum for Ambulatory Care Nursing","author":"Albert","year":"2013","edition":"3rd"},{"issue":"5","key":"2019112612174391100_b56-0380016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1474515114540756","article-title":"Hospital nurses\u2019 comfort in and frequency of delivering heart failure self-care education","volume":"14","author":"Albert","year":"2015","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2019112612174391100_b57-0380016","first-page":"897190017743129","article-title":"Implementation of a cardiac transitions of care pilot program: a prospective study of inpatient and outpatient clinical pharmacy services for patients with heart failure exacerbation or acute myocardial infarction","volume":"1","author":"Murphy","year":"2017","journal-title":"J Pharm Pract"},{"key":"2019112612174391100_b58-0380016","doi-asserted-by":"crossref","first-page":"pii:e002946","DOI":"10.1161\/CIRCOUTCOMES.116.002946","article-title":"Characterization of miner-alocorticoid receptor antagonist therapy initiation in high-risk patients with heart failure","volume":"10","author":"Cooper","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"2019112612174391100_b59-0380016","first-page":"561","article-title":"Treatment initiation patterns, modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis","volume":"22","author":"Deschaseaux","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"2019112612174391100_b60-0380016","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.115.014281","article-title":"Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality measures","volume":"132","author":"Allen","year":"2015","journal-title":"Circulation"},{"key":"2019112612174391100_b61-0380016","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ahj.2013.03.007","article-title":"Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure","volume":"165","author":"Curtis","year":"2013","journal-title":"Am Heart J"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/38\/5\/16\/116285\/16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/38\/5\/16\/116285\/16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T17:49:31Z","timestamp":1574790571000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/38\/5\/16\/20791\/InHospital-Initiation-of-GuidelineDirected-Heart"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2018669","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}